Exelixis (EXEL) Research & Development (2010 - 2026)

Exelixis' Research & Development history runs 17 years deep, the most recent figure standing at $199.9 million for Q2 2026.

• In Q2 2026, Research & Development fell 5.8% year-over-year to $199.9 million; the TTM figure through Apr 2026 stood at $812.7 million (down 9.19% YoY), while the FY2026 annual figure was $825.0 million, down 9.38% from the prior year.
• Research & Development was $199.9 million for Q2 2026 at Exelixis, down from $213.2 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $336.8 million in Q4 2022 to a low of $156.7 million in Q2 2022.
• Historically, Research & Development has averaged $227.7 million across 5 years, with a median of $213.2 million in 2026.
• The sharpest annual moves came in 2022 and 2024: Research & Development surged 512.41% in 2022, then tumbled 33.08% in 2024.
• A 5-year view of Research & Development shows it stood at $336.8 million in 2022, then fell by 27.36% to $244.7 million in 2023, then fell by 9.03% to $222.6 million in 2024, then retreated by 10.52% to $199.2 million in 2025, then increased by 0.38% to $199.9 million in 2026.
• The last three Research & Development figures came in at $199.9 million (Q2 2026), $213.2 million (Q1 2026), and $199.2 million (Q4 2025), per Business Quant data.